These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2949586)

  • 1. Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart.
    Hof RP; Salzmann R; Siegl H
    Am J Cardiol; 1987 Jan; 59(3):30B-36B. PubMed ID: 2949586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits.
    Hof RP
    Am J Cardiol; 1987 Jan; 59(3):37B-42B. PubMed ID: 2949587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.
    Hof RP; Hof A; Scholtysik G; Menninger K
    J Cardiovasc Pharmacol; 1984; 6(3):407-16. PubMed ID: 6202965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepression.
    Cook NS; Hof RP
    Br J Pharmacol; 1985 Sep; 86(1):181-9. PubMed ID: 2932193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell ionized calcium concentration in spontaneous hypertension: modulation in vivo by the calcium antagonist PN 200.110.
    Morris MJ; David-Dufilho M; Devynck MA
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):257-60. PubMed ID: 2978740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological properties of isradipine (PN200-110) in humans.
    van Wijk LM; van den Toren WE; van Gelder I; Crijns HJ; Ruegg P; Lie KI
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):492-5. PubMed ID: 2476631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cardiovascular profile among calcium antagonists.
    Taira N
    Am J Cardiol; 1987 Jan; 59(3):24B-29B. PubMed ID: 3544789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial properties of the new dihydropyridine calcium antagonist isradipine compared to nifedipine with or without additional beta blockade in coronary artery disease.
    Mauser M; Voelker W; Ickrath O; Karsch KR
    Am J Cardiol; 1989 Jan; 63(1):40-4. PubMed ID: 2562817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral cardiovascular effects of the enantiomers of the calcium antagonist PN 200-110.
    Briand V; Laurent S; Tsoucaris-Kupfer D; Legrand M; Brisac AM; Schmitt H
    Eur J Pharmacol; 1988 May; 150(1-2):43-50. PubMed ID: 2969823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.
    Barrès C; Cerutti C; Morin B; Sassard J
    Br J Pharmacol; 1988 Jan; 93(1):176-84. PubMed ID: 2964887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
    Hof RP
    Am J Cardiol; 1987 Jan; 59(3):43B-51B. PubMed ID: 2880495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN
    Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine.
    Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E
    J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
    Mauser M; Voelker W; Karsch KR
    Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine.
    Schachter M
    J Clin Pharm Ther; 1991 Apr; 16(2):79-91. PubMed ID: 1830320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dihydropyridines on tension and calcium-45 influx in isolated mesenteric resistance vessels from spontaneously hypertensive and normotensive rats.
    Cauvin C; Hwang O; Yamamoto M; van Breemen C
    Am J Cardiol; 1987 Jan; 59(3):116B-122B. PubMed ID: 2433929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.